UPDATE : Monday, September 7, 2020
상단여백
Takeda Korea labor union to ask Japanese headquarters about restructuring
Takeda Pharmaceutical Korea’s trade union, in dispute with management durin...
by Kim Yun-mi  |  2019-09-19 14:11
라인
Chong Kun Dang releases trial result for diabetes treatment
Chong Kun Dang said that it has presented a clinical trial result, which it...
by Lee Han-soo  |  2019-09-19 14:11
라인
Indian biosimilar of rituximab to undergo test in Korea
India’s largest generics drugmaker Dr. Reddy's Laboratories said it wou...
by Lee Hye-seon  |  2019-09-19 10:31
라인
Ono Pharma, BMS unveil two P3 trial analyses for Opdivo
Ono Pharmaceutical and Bristol-Myers Squibb have presented pooled data on t...
by Lee Han-soo  |  2019-09-18 15:48
라인
CJ Healthcare to export gastroesophageal reflux treatment to Indonesia
CJ Healthcare said that it plans to export K-CAB (Ingredient: tegoprazan), ...
by Lee Han-soo  |  2019-09-18 11:37
라인
Will Tagrisso study results affect use of EGFR TKIs in lung cancer?
AstraZeneca’s imminent announcement of overall survival (OS) data of Tagris...
by Kim Yun-mi  |  2019-09-18 11:36
라인
Hanmi spurs new immunotherapy development through open innovation
Hanmi Pharmaceutical said it is launching new development projects in the f...
by Lee Han-soo  |  2019-09-17 18:14
라인
‘Lundbeck to work with parliament to prevent suicide in Korea’
Lundbeck, which sells anti-depressants Lexapro and Brintellix, dementia tre...
by Kim Yun-mi  |  2019-09-17 15:19
라인
Shinpoong's malaria treatment expands global presence
Shinpoong Pharmaceutical said that Pyramax, its malaria treatment, is quick...
by Lee Han-soo  |  2019-09-17 15:13
라인
SK Bioscience to export influenza vaccine to Asian countries
SK Bioscience will export 250,000 doses of Skycellflu, the first cell-cultu...
by Lee Han-soo  |  2019-09-17 11:27
라인
Lenvima to get benefit as 1st-line treatment of hepatocellular carcinoma
Lenvima (ingredient: lenvatinib), a new liver cancer drug that arrived in a...
by Kim Yun-mi  |  2019-09-16 16:20
라인
'Roche Korea to put patient accessibility first'
Roche Korea, the number one company in the domestic anticancer market, is l...
by Lee Han-soo  |  2019-09-16 15:41
라인
GC’s Hunter syndrome drug to get priority screening in China
GC said that China’s National Medical Products Administration (NMPA) has de...
by Lee Han-soo  |  2019-09-16 13:56
라인
GSK’s chronic hand eczema treatment faces local competition
GSK Korea is facing competition from DongKoo Bio&Pharma for its exclusive c...
by Lee Han-soo  |  2019-09-12 07:22
라인
Chong Kun Dang wins patent suit against Novartis over immunosuppressant
Chong Kun Dang said it has won the lawsuit against Novartis over the patent...
by Jeong Sae-im  |  2019-09-11 15:16
라인
AstraZeneca to challenge Roche in small-cell lung cancer treatment market
AstraZeneca’s Imfinzi (ingredient: durvalumab) has sharpened up its weapon ...
by Kim Yun-mi  |  2019-09-11 14:18
라인
Amgen fetes 1st anniversary of getting expanded indication for Repatha
Amgen Korea said that its cardio-vascular disease business unit has held an...
by Lee Han-soo  |  2019-09-11 13:56
라인
Hanmi to launch 3-substance combination in Latin America
Hanmi Pharmaceutical said that it has become the first local corporation to...
by Lee Han-soo  |  2019-09-11 13:56
라인
Daewoong to test botulinum toxin Nabota for hair loss
Daewoong Pharmaceutical said it would conduct a clinical trial on botulinum...
by Jeong Sae-im  |  2019-09-11 13:56
라인
Novartis withdraws suit against Ahngook’s generic drug
Novartis canceled its lawsuit against Ahngook Pharmaceutical’s anti-diabeti...
by Jeong Sae-im  |  2019-09-10 15:38
여백
여백
여백
Back to Top